Clinical Trials Logo

Filter by:
NCT ID: NCT04316468 Terminated - Reperfusion Injury Clinical Trials

Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation

Start date: March 10, 2020
Phase:
Study type: Observational

Researchers are trying to improve the understanding of systolic function of the heart at the time of liver reperfusion in patients undergoing orthotopic liver transplantation.

NCT ID: NCT04315961 Terminated - Healthy Clinical Trials

Effects of Dietary Conditions on Drug Response

Start date: September 18, 2020
Phase: Phase 1
Study type: Interventional

This non-treatment study will examine how different dietary conditions may affect a person's response to commonly used drugs.

NCT ID: NCT04315883 Terminated - Clinical trials for Hepatocellular Carcinoma

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Start date: February 11, 2021
Phase:
Study type: Observational

This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Liver Tumors. The treatment and techniques used here are well established in adults. The purpose of this study is to evaluate: 1. the response to treatment and clinical outcomes of treatment with TARE Y-90 as part of standard therapy and 2. to assess the change in the patient's quality of life before, during and after treatment with TARE-Y90

NCT ID: NCT04314843 Terminated - Clinical trials for Relapsed/Refractory Large B-cell Lymphoma

Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma

ZUMA-19
Start date: May 26, 2020
Phase: Phase 1
Study type: Interventional

The primary objectives of this study are: Phase 1: To evaluate the safety of sequenced therapy with lenzilumab and axicabtagene ciloleucel in participants with relapsed or refractory large B-cell lymphoma and identify the most appropriate dose of lenzilumab for Phase 2. Phase 2: To evaluate the incidence of neurologic events with sequenced therapy given at the recommended Phase 2 dose (RP2D) of lenzilumab in participants with relapsed or refractory large B-cell lymphoma.

NCT ID: NCT04314713 Terminated - Clinical trials for Scopolamine Causing Adverse Effects in Therapeutic Use

A Study to Evaluate the Intramuscular Administration of Scopolamine

Start date: June 2, 2020
Phase: Phase 1
Study type: Interventional

To characterize the safety and tolerability profile of ascending doses of scopolamine hydrobromide trihydrate (Scopolamine HBT) administered by intramuscular (IM) injection. And characterize the pharmacokinetics (PK) of ascending doses of Scopolamine HBT administered by IM injection

NCT ID: NCT04314700 Terminated - Clinical trials for Breast Cancer Female

Intraoperative Use of an Optical Coherence Tomography (OCT) Imaging System to Guide Additional Margin Cavity Shaves in Breast Conserving Surgery (BCS)

Start date: February 11, 2020
Phase: N/A
Study type: Interventional

Female patients undergoing a breast conserving procedure will be consented for the excised breast tissue to be imaged on an investigational OCT-based device. Additional tissue may be excised to obtain clear/negative margins based on routine standard of care tissue assessment techniques and intraoperative OCT image review.

NCT ID: NCT04313985 Terminated - Clinical trials for PAD - Peripheral Arterial Disease

Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to apply Avazzia micro-current stimulation to patients with chronic, non-healing wounds to determine if this therapy is effective in perfusion and bacterial measurements.

NCT ID: NCT04313881 Terminated - Clinical trials for Myelodysplastic Syndromes

Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)

ENHANCE
Start date: September 9, 2020
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of magrolimab in combination with azacitidine compared to that of azacitidine plus placebo in previously untreated participants with intermediate/high/very high risk myelodysplastic syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) as measured by complete remission (CR) and overall survival (OS).

NCT ID: NCT04313296 Terminated - Atrial Fibrillation Clinical Trials

Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Atrial fibrillation (AF) is the most common heart rhythm disorder seen in clinical practice, with an estimated 2.7-6.1 million people in the U.S. affected by the disorder [1]. Previous studies have demonstrated that left atrial volume is a predictive measure of incident atrial fibrillation [2]. This study aims to add to the literature by investigating predictive measures of left atrial global longitudinal strain (LA GLS) that would be suggestive of maintenance of normal sinus rhythm post cardioversion. If the investigators could gain insight on the connection between LA GLS and cardioversion among patients with atrial fibrillation, the investigators could potentially help the clinical management of patients pre/post cardioversion, and potentially change poor outcomes.

NCT ID: NCT04313179 Terminated - Pain Clinical Trials

Music Therapy for Pain Management for Minor Procedures in Neonates.

Start date: April 9, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to assess the effectiveness and safety of music therapy as adjuvant therapy for pain management in newborns undergoing minor painful procedures. It is a prospective study and we plan to enroll 200 healthy full term newborns undergoing minor procedures (heel pricks). They will be randomly assigned to either control or music group. Those in music group will receive recorded Mozart lullaby music. Pain will be assessed using NIPS (Neonatal Infant Pain Scale) scoring tool. The potential benefit of the study would be identifying music a safe and efficient adjuvant therapy for pain management in newborns.